Threshold Pharmaceuticals completes enrollment in phase II TH-302 pancreatic cancer trial June 23, 2011
GTx begins phase IIb trial comparing Capesaris to Lupron Depot in advanced prostate cancer June 21, 2011
Photocure begins enrolling women with CIN due to HPV infection in phase II Cevira trial June 21, 2011
RSS